NOVOZYMES BIOINDUSTRIAL A/S: Financial statements 2022
CVR: 24257908
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
NOVOZYMES BIOINDUSTRIAL A/S (CVR 24257908) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -36,983 and a net result of DKK -2,970,513 compared with DKK 637,465 the year before. Equity in the 2022 report amounted to DKK 29,003,969. The solvency ratio was 99.9%.
- Gross Profit
- DKK -36,983
- Profit/Loss
- DKK -2,970,513
- Equity
- DKK 29,003,969
- Total Assets
- DKK 29,039,342
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -37K | -3M | 29M | 0 |
| 2021 | - | -32K | 637K | 29.5M | 0 |
| 2020 | - | -32K | 2.5M | 28.8M | 0 |
| 2019 | - | -38K | -32K | 26.4M | 0 |
| 2018 | - | -58K | -4.8M | 26.4M | - |
Official annual report
Keep an eye on NOVOZYMES BIOINDUSTRIAL A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
NOVOZYMES BIOINDUSTRIAL A/S has published its annual report for 2021. Gross profit came to DKK -32,188, and the net result was DKK 637,465.
About NOVOZYMES BIOINDUSTRIAL A/S
NOVOZYMES BIOINDUSTRIAL A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1974. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named NOVO NORDISK BIOINDUSTRIAL A/S and NOVO ENZYM A/S. The management consists of Lisbet Kragelund. The board consists of Mikkel Viltoft (chair), Lisbet Kragelund and Rainer Chapour Lehmann. The company is owned by NOVOZYMES A/S. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,056 and a net result of DKK -44,180 compared with DKK -41,700 the year before. Equity in the 2025 report amounted to DKK 24,891,057.